불임 치료 서비스 시장 : 시장 점유율 및 순위, 전체 매출 및 수요 예측(2024-2030년)

The global market for Infertility Services was estimated to be worth US$ 7,191.14 million in 2023 and is forecast to a readjusted size of US$ 11,821.64 million by 2030 with a CAGR of 7.41% during the forecast period 2024-2030.

North American market for Infertility Services was valued at $ 2,317.7 million in 2023 and will reach $ 3,834.4 million by 2030, at a CAGR of 7.39% during the forecast period of 2024 through 2030.

Asia-Pacific market for Infertility Services was valued at $ 3,211.56 million in 2023 and will reach $ 5,454.41 million by 2030, at a CAGR of 8% during the forecast period of 2024 through 2030.

Europe market for Infertility Services was valued at $ 1,405.15 million in 2023 and will reach $ 2,171.09 million by 2030, at a CAGR of 6.43% during the forecast period of 2024 through 2030.

The global key companies of Infertility Services include: Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, Jinxin Fertility, LIVZON, and Abbott, etc. In 2023, the global five largest players hold a share approximately 23.32% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Infertility Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infertility Services by region & country, by Type, and by Application.

The Infertility Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Services.

Market Segmentation

By Company

• Ferring Pharmaceuticals
• Merck
• Jinxin Fertility
• Vitrolife
• Mayo Clinic
• LIVZON
• Abbott
• Monash IVF
• CARE Facility
• Theramex
• TriHealth
• NMC Health
• CooperSurgical
• Irvine Scientific
• Virtus Health
• CinnaGen
• OB GYN Associates
• Caerus Biotech
• InVitroCare
• INVO Bioscience

Segment by Type

• Assisted Reproductive Technology (ART)
• Infertility Drug Services
• Others

Segment by Application

• Male
• Female

By Region

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe

• South America
  • Mexico
  • Brazil
  • Rest of South America

• Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Infertility Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Infertility Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Infertility Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Infertility Services Product Introduction
• 1.2 Global Infertility Services Market Size Forecast (2019-2030)
• 1.3 Infertility Services Market Trends & Drivers
  • 1.3.1 Infertility Services Industry Trends
  • 1.3.2 Infertility Services Market Drivers & Opportunity
  • 1.3.3 Infertility Services Market Challenges
  • 1.3.4 Infertility Services Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Infertility Services Players Revenue Ranking (2023)
• 2.2 Global Infertility Services Revenue by Company (2019-2024)
• 2.3 Key Companies Infertility Services Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Infertility Services Product Offered
• 2.5 Infertility Services Market Competitive Analysis
  • 2.5.1 Infertility Services Market Concentration Rate (2019-2024)
  • 2.5.2 Global 5 and 10 Largest Companies by Infertility Services Revenue in 2023
  • 2.5.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2023)
• 2.6 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Assisted Reproductive Technology (ART)
  • 3.1.2 Infertility Drug Services
  • 3.1.3 Others
• 3.2 Global Infertility Services Sales Value by Type
  • 3.2.1 Global Infertility Services Sales Value by Type (2019 VS 2023 VS 2030)
  • 3.2.2 Global Infertility Services Sales Value, by Type (2019-2030)
  • 3.2.3 Global Infertility Services Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

• 4.1 Introduction by Application
• 4.2 Global Infertility Services Sales Value by Application
  • 4.2.1 Global Infertility Services Sales Value by Application (2019 VS 2023 VS 2030)
  • 4.2.2 Global Infertility Services Sales Value, by Application (2019-2030)
  • 4.2.3 Global Infertility Services Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

• 5.1 Global Infertility Services Sales Value by Region
  • 5.1.1 Global Infertility Services Sales Value by Region: 2019 VS 2023 VS 2030
  • 5.1.2 Global Infertility Services Sales Value by Region (2019-2024)
  • 5.1.3 Global Infertility Services Sales Value by Region (2025-2030)
  • 5.1.4 Global Infertility Services Sales Value by Region (%), (2019-2030)
• 5.2 North America
  • 5.2.1 North America Infertility Services Sales Value, 2019-2030
  • 5.2.2 North America Infertility Services Sales Value by Country (%), 2023 VS 2030
• 5.3 Europe
  • 5.3.1 Europe Infertility Services Sales Value, 2019-2030
  • 5.3.2 Europe Infertility Services Sales Value by Country (%), 2023 VS 2030
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Infertility Services Sales Value, 2019-2030
  • 5.4.2 Asia Pacific Infertility Services Sales Value by Region (%), 2023 VS 2030
• 5.5 South America
  • 5.5.1 South America Infertility Services Sales Value, 2019-2030
  • 5.5.2 South America Infertility Services Sales Value by Country (%), 2023 VS 2030
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Infertility Services Sales Value, 2019-2030
  • 5.6.2 Middle East & Africa Infertility Services Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Infertility Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
• 6.2 Key Countries/Regions Infertility Services Sales Value, 2019-2030
• 6.3 United States
  • 6.3.1 United States Infertility Services Sales Value, 2019-2030
  • 6.3.2 United States Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 United States Infertility Services Sales Value by Application, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe Infertility Services Sales Value, 2019-2030
  • 6.4.2 Europe Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe Infertility Services Sales Value by Application, 2023 VS 2030
• 6.5 China
  • 6.5.1 China Infertility Services Sales Value, 2019-2030
  • 6.5.2 China Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.5.3 China Infertility Services Sales Value by Application, 2023 VS 2030
• 6.6 Japan
  • 6.6.1 Japan Infertility Services Sales Value, 2019-2030
  • 6.6.2 Japan Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 Japan Infertility Services Sales Value by Application, 2023 VS 2030
• 6.7 South Korea
  • 6.7.1 South Korea Infertility Services Sales Value, 2019-2030
  • 6.7.2 South Korea Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 South Korea Infertility Services Sales Value by Application, 2023 VS 2030
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Infertility Services Sales Value, 2019-2030
  • 6.8.2 Southeast Asia Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.8.3 Southeast Asia Infertility Services Sales Value by Application, 2023 VS 2030
• 6.9 India
  • 6.9.1 India Infertility Services Sales Value, 2019-2030
  • 6.9.2 India Infertility Services Sales Value by Type (%), 2023 VS 2030
  • 6.9.3 India Infertility Services Sales Value by Application, 2023 VS 2030

7 Company Profiles

• 7.1 Ferring Pharmaceuticals
  • 7.1.1 Ferring Pharmaceuticals Profile
  • 7.1.2 Ferring Pharmaceuticals Main Business
  • 7.1.3 Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
  • 7.1.4 Ferring Pharmaceuticals Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.2 Merck
  • 7.2.1 Merck Profile
  • 7.2.2 Merck Main Business
  • 7.2.3 Merck Infertility Services Products, Services and Solutions
  • 7.2.4 Merck Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.3 Jinxin Fertility
  • 7.3.1 Jinxin Fertility Profile
  • 7.3.2 Jinxin Fertility Main Business
  • 7.3.3 Jinxin Fertility Infertility Services Products, Services and Solutions
  • 7.3.4 Jinxin Fertility Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.4 Vitrolife
  • 7.4.1 Vitrolife Profile
  • 7.4.2 Vitrolife Main Business
  • 7.4.3 Vitrolife Infertility Services Products, Services and Solutions
  • 7.4.4 Vitrolife Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.5 Mayo Clinic
  • 7.5.1 Mayo Clinic Profile
  • 7.5.2 Mayo Clinic Main Business
  • 7.5.3 Mayo Clinic Infertility Services Products, Services and Solutions
  • 7.5.4 Mayo Clinic Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.6 LIVZON
  • 7.6.1 LIVZON Profile
  • 7.6.2 LIVZON Main Business
  • 7.6.3 LIVZON Infertility Services Products, Services and Solutions
  • 7.6.4 LIVZON Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.7 Abbott
  • 7.7.1 Abbott Profile
  • 7.7.2 Abbott Main Business
  • 7.7.3 Abbott Infertility Services Products, Services and Solutions
  • 7.7.4 Abbott Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.8 Monash IVF
  • 7.8.1 Monash IVF Profile
  • 7.8.2 Monash IVF Main Business
  • 7.8.3 Monash IVF Infertility Services Products, Services and Solutions
  • 7.8.4 Monash IVF Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.8.5 Monash IVF Recent Developments
• 7.9 CARE facility
  • 7.9.1 CARE facility Profile
  • 7.9.2 CARE facility Main Business
  • 7.9.3 CARE facility Infertility Services Products, Services and Solutions
  • 7.9.4 CARE facility Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.10 Theramex
  • 7.10.1 Theramex Profile
  • 7.10.2 Theramex Main Business
  • 7.10.3 Theramex Infertility Services Products, Services and Solutions
  • 7.10.4 Theramex Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.11 TriHealth
  • 7.11.1 TriHealth Profile
  • 7.11.2 TriHealth Main Business
  • 7.11.3 TriHealth Infertility Services Products, Services and Solutions
  • 7.11.4 TriHealth Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.12 NMC Health
  • 7.12.1 NMC Health Profile
  • 7.12.2 NMC Health Main Business
  • 7.12.3 NMC Health Infertility Services Products, Services and Solutions
  • 7.12.4 NMC Health Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.13 CooperSurgical
  • 7.13.1 CooperSurgical Profile
  • 7.13.2 CooperSurgical Main Business
  • 7.13.3 CooperSurgical Infertility Services Products, Services and Solutions
  • 7.13.4 CooperSurgical Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.14 Irvine Scientific
  • 7.14.1 Irvine Scientific Profile
  • 7.14.2 Irvine Scientific Main Business
  • 7.14.3 Irvine Scientific Infertility Services Products, Services and Solutions
  • 7.14.4 Irvine Scientific Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.15 Virtus Health
  • 7.15.1 Virtus Health Profile
  • 7.15.2 Virtus Health Main Business
  • 7.15.3 Virtus Health Infertility Services Products, Services and Solutions
  • 7.15.4 Virtus Health Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.16 CinnaGen
  • 7.16.1 CinnaGen Profile
  • 7.16.2 CinnaGen Main Business
  • 7.16.3 CinnaGen Infertility Services Products, Services and Solutions
  • 7.16.4 CinnaGen Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.17 OB GYN Associates
  • 7.17.1 OB GYN Associates Profile
  • 7.17.2 OB GYN Associates Main Business
  • 7.17.3 OB GYN Associates Infertility Services Products, Services and Solutions
  • 7.17.4 OB GYN Associates Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.18 Caerus Biotech
  • 7.18.1 Caerus Biotech Profile
  • 7.18.2 Caerus Biotech Main Business
  • 7.18.3 Caerus Biotech Infertility Services Products, Services and Solutions
  • 7.18.4 Caerus Biotech Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.19 InVitroCare
  • 7.19.1 InVitroCare Profile
  • 7.19.2 InVitroCare Main Business
  • 7.19.3 InVitroCare Infertility Services Products, Services and Solutions
  • 7.19.4 InVitroCare Infertility Services Revenue (US$ Million) & (2019-2024)
• 7.20 INVO Bioscience
  • 7.20.1 INVO Bioscience Profile
  • 7.20.2 INVO Bioscience Main Business
  • 7.20.3 INVO Bioscience Infertility Services Products, Services and Solutions
  • 7.20.4 INVO Bioscience Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.20.5 INVO Bioscience Recent Developments

8 Industry Chain Analysis

• 8.1 Infertility Services Industrial Chain
• 8.2 Infertility Services Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer